Skip to main content
Clinical Trials/NCT07605832
NCT07605832Not yet recruitingNot Applicable

Children With Surgically Corrected Acyanotic Congenital Heart Disease

Delta University for Science and Technology1 site in 1 country80 target enrollmentStarted: May 31, 2026Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
80
Locations
1

Study Overview

Brief Summary

The goal of this quasi-experimental pretest-posttest controlled study is to learn whether moderate-intensity treadmill exercise can improve gait kinematics, walking capacity, and motor performance in preschool children aged 48-72 months with surgically corrected acyanotic congenital heart disease.

The main questions it aims to answer are:

Does moderate-intensity treadmill training improve gait kinematics, including stride length, walking speed, and double-stance percentage? Does moderate-intensity treadmill training improve walking capacity and balance in children with surgically corrected acyanotic congenital heart disease?

Researchers compared children with surgically corrected acyanotic congenital heart disease who received treadmill training with age-matched healthy children to see whether the exercise program could reduce gait, balance, and walking-capacity differences between the groups.

Participants with congenital heart disease completed:

Four treadmill walking sessions per week for 10 weeks. Moderate-intensity walking at approximately 70% of maximal heart rate. Pre- and post-intervention assessments of gait kinematics using three-dimensional motion analysis.

Balance assessment using the Pediatric Balance Scale. Walking capacity assessment using the six-minute walk test.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
48 Months to 72 Months (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • For cyanotic postoperative congenital heart disease group:
  • Children diagnosed with acyanotic postoperative congenital heart disease.
  • Underwent surgical repair for CHD.
  • Has a history of only one surgical intervention.
  • Age between 48 and 72 months.
  • Mentally normal, with an IQ between 85 and
  • For the healthy control group (HCG):
  • For healthy children aged 48 to 72 months. Full school attendance. Full participation in social and recreational activities. Parents/guardians provided written informed consent.

Exclusion Criteria

  • Children were excluded if they had:
  • Genetic disorders.
  • Severe neurological disorders.
  • Cyanotic congenital heart disease.
  • Perinatal complications.

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials